Primary Outcome
Three months after randomization, 14 of the 24 participants (58%) randomized to the SA group had a reduction of at least 50% in the PHQ-9 score compared with 10 of 23 participants (43%) in the NSA group. The result was not statistically significant (risk ratio [RR], 1.34; 95% CI, 0.76-2.45; 